Strides Pharma Science Limited

Informe acción NSEI:STAR

Capitalización de mercado: ₹81.2b

Strides Pharma Science Dirección

Dirección controles de criterios 2/4

El CEO de Strides Pharma Science's es Arun Pillai , nombrado en Apr 2022, tiene una permanencia de 33.83 años. compensación anual total es ₹60.00M, compuesta por 0% salario y 100% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.11% de las acciones de la empresa, por valor de ₹1.64B. La antigüedad media del equipo directivo y de la junta directiva es de 4.6 años y 8.3 años, respectivamente.

Información clave

Arun Pillai

Chief Executive Officer (CEO)

₹60.0m

Compensación total

Porcentaje del salario del CEO0.0%
Permanencia del CEO2yrs
Participación del CEO2.1%
Permanencia media de la dirección4.6yrs
Promedio de permanencia en la Junta Directiva8.3yrs

Actualizaciones recientes de la dirección

Recent updates

Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Apr 04
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Sep 26
We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Jun 08
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Aug 02
Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Jun 25
Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Dec 21
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Apr 13
Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

Mar 04
Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Feb 15
These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

Jan 26
Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Jan 11
The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Dec 28
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Nov 25
Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares

Aug 17
Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares

What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E

Aug 11
What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Arun Pillai en comparación con los beneficios de Strides Pharma Science?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-₹2b

Sep 30 2023n/an/a

-₹2b

Jun 30 2023n/an/a

-₹924m

Mar 31 2023₹60m₹1

-₹2b

Dec 31 2022n/an/a

-₹2b

Sep 30 2022n/an/a

-₹2b

Jun 30 2022n/an/a

-₹4b

Mar 31 2022₹800kn/a

-₹5b

Dec 31 2021n/an/a

-₹4b

Sep 30 2021n/an/a

-₹3b

Jun 30 2021n/an/a

-₹543m

Mar 31 2021₹8mn/a

₹3b

Dec 31 2020n/an/a

₹28m

Sep 30 2020n/an/a

₹589m

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹72m₹49m

₹492m

Dec 31 2019n/an/a

₹3b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹745m

Mar 31 2019₹50m₹38m

₹840m

Dec 31 2018n/an/a

-₹93m

Sep 30 2018n/an/a

₹139m

Jun 30 2018n/an/a

₹415m

Mar 31 2018₹106m₹14m

₹544m

Compensación vs. Mercado: La compensación total de Arun($USD719.64K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD381.18K).

Compensación vs. Ingresos: La compensación de Arun ha aumentado mientras la empresa no es rentable.


CEO

Arun Pillai (62 yo)

2yrs

Permanencia

₹60,000,001

Compensación

Mr. Arun Kumar Pillai, B.Com., is Founder of Solara Active Pharma Sciences Limited and serves as its Non-Executive Director since August 04, 2021 and its Founder. Mr. Pillai has been Executive Chairperson...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Arun Pillai
Founder2yrs₹60.00m2.11%
₹ 1.7b
Badree Komandur
Group CFO10.7yrs₹44.00m0.027%
₹ 22.1m
Manjula Ramamurthy
Compliance Officer & Company Secretary7.2yrs₹5.86msin datos
P. V. Ramaraju
Chief Operating Officerless than a yearsin datossin datos
Sormistha Ghosh
Group General Counsel & Chief Risk Officerno datasin datossin datos
C. Sundar
Executive Vice President of Operationsno datasin datossin datos
Kevin Cook
Senior Vice President of Strides Pharma Inc.no datasin datossin datos
Umesh Kale
Chief Quality Officerno datasin datossin datos
A. Narayanan
Chief Information Technology Officerno datasin datossin datos
Vinod Nair
Senior Vice President of Institutional Businessno datasin datossin datos
Amol Mehta
Senior Vice President of Regulated Marketsno datasin datossin datos
Amit Gupta
Senior Vice President of Taxationno datasin datossin datos

4.6yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de STAR se considera experimentado (4.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Arun Pillai
Founder33.8yrs₹60.00m2.11%
₹ 1.7b
Badree Komandur
Group CFO6.9yrs₹44.00m0.027%
₹ 22.1m
Homi Khusrokhan
Independent Director6.9yrs₹2.20msin datos
Srinivasan Sridhar
Independent Director11.8yrs₹2.20msin datos
Dennis Bastas
Executive Chairman of Arrow Pharmaceuticals Pty Ltdno datasin datossin datos
Gopakumar Nair
Member of Scientific Advisory Boardno datasin datossin datos
Elias Neto
Member of Scientific Advisory Boardno datasin datossin datos
S. Vyas
Member of Scientific Advisory Boardno datasin datossin datos
B. Suresh
Member of Scientific Advisory Boardno datasin datossin datos
C. Gupta
Member of Scientific Advisory Boardno datasin datossin datos
Bharat Shah
Independent Director9.8yrs₹2.20m0.083%
₹ 67.5m
Kausalya Santhanam
Independent Director4.3yrs₹2.20m0.0013%
₹ 1.1m

8.3yrs

Permanencia media

72yo

Promedio de edad

Junta con experiencia: La junta directiva de STAR se considera experimentada (8.3 años de antigüedad promedio).